These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16107369)

  • 1. Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?
    de Leeuw FE; Barkhof F; Scheltens P
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1286-8. PubMed ID: 16107369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High blood pressure and cerebral white matter lesion progression in the general population.
    Verhaaren BF; Vernooij MW; de Boer R; Hofman A; Niessen WJ; van der Lugt A; Ikram MA
    Hypertension; 2013 Jun; 61(6):1354-9. PubMed ID: 23529163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
    Targosz-Gajniak M; Siuda J; Ochudło S; Opala G
    J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
    J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.
    Claus JJ; Coenen M; Staekenborg SS; Schuur J; Tielkes CEM; Koster P; Scheltens P
    J Alzheimers Dis; 2018; 63(3):1129-1139. PubMed ID: 29710708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
    Korf ES; Scheltens P; Barkhof F; de Leeuw FE
    Dement Geriatr Cogn Disord; 2005; 20(6):331-7. PubMed ID: 16179827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter lesions - age-adjusted values for cognitively healthy and demented subjects.
    Hentschel F; Damian M; Krumm B; Froelich L
    Acta Neurol Scand; 2007 Mar; 115(3):174-80. PubMed ID: 17295712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of cerebral white matter lesions -- clinical and radiological considerations.
    Enzinger C; Fazekas F; Ropele S; Schmidt R
    J Neurol Sci; 2007 Jun; 257(1-2):5-10. PubMed ID: 17321549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease.
    Hanaoka T; Kimura N; Aso Y; Takemaru M; Kimura Y; Ishibashi M; Matsubara E
    Geriatr Gerontol Int; 2016 Jul; 16(7):836-42. PubMed ID: 26245516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions.
    Liu W; Liu R; Sun W; Peng Q; Zhang W; Xu E; Cheng Y; Ding M; Li Y; Hong Z; Wu J; Zeng J; Yao C; Huang Y;
    Stroke; 2012 Nov; 43(11):2916-22. PubMed ID: 22949472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease.
    Connelly PJ; Prentice NP; Fowler KG
    Int J Geriatr Psychiatry; 2005 Jul; 20(7):623-8. PubMed ID: 16021654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
    Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
    Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.
    Jonsson M; Zetterberg H; Rolstad S; Edman A; Gouw AA; Bjerke M; Lind K; Blennow K; Pantoni L; Inzitari D; Wallin A
    Dement Geriatr Cogn Disord; 2012; 34(1):61-7. PubMed ID: 22922641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure.
    De Leeuw FE; Barkhof F; Scheltens P
    J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1270-4. PubMed ID: 15314113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.
    Weber R; Weimar C; Blatchford J; Hermansson K; Wanke I; Möller-Hartmann C; Gizewski ER; Forsting M; Demchuk AM; Sacco RL; Saver JL; Warach S; Diener HC; Diehl A;
    Stroke; 2012 Sep; 43(9):2336-42. PubMed ID: 22738922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.
    Schmidt R; Berghold A; Jokinen H; Gouw AA; van der Flier WM; Barkhof F; Scheltens P; Petrovic K; Madureira S; Verdelho A; Ferro JM; Waldemar G; Wallin A; Wahlund LO; Poggesi A; Pantoni L; Inzitari D; Fazekas F; Erkinjuntti T;
    Stroke; 2012 Oct; 43(10):2643-7. PubMed ID: 22879094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter lesions and hippocampal atrophy in Alzheimer's disease.
    de Leeuw FE; Barkhof F; Scheltens P
    Neurology; 2004 Jan; 62(2):310-2. PubMed ID: 14745078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.